Adamis Pharmaceuticals reported -9763290 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Adma Biologics ADMA:US $ -21.48M 8.29M
Brainstorm Cell Therapeutics BCLI:US $ -5475000 737K
Cara Therapeutics CARA:US $ -27911000 5.61M
Cerulean Pharma CERU:US $ -8400450 1.14M
GlaxoSmithKline GSK:LN 1.08B 1.72B
Glaxosmithkline GSK:US $ 1081M 1720M
Merk MRK:US $ 4927M 642M
Pfizer PFE:US $ 12102M 2229M
Redhill Biopharma RDHL:US $ -13.24M 7.46M